Vimal Mehta
2017
In 2017, Vimal Mehta earned a total compensation of $283.5K as President and Chief Executive Officer at BioXcel Therapeutics.
Compensation breakdown
Option Awards | $125,932 |
---|---|
Salary | $147,000 |
Other | $10,599 |
Total | $283,531 |
Mehta received $147K in salary, accounting for 52% of the total pay in 2017.
Mehta also received $125.9K in option awards and $10.6K in other compensation.
Rankings
In 2017, Vimal Mehta's compensation ranked 13,463rd out of 14,666 executives tracked by ExecPay. In other words, Mehta earned more than 8.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 13,463 out of 14,666 | 8th |
Division Manufacturing | 5,295 out of 5,772 | 8th |
Major group Chemicals And Allied Products | 1,911 out of 2,075 | 8th |
Industry group Drugs | 1,595 out of 1,731 | 8th |
Industry Pharmaceutical Preparations | 1,227 out of 1,333 | 8th |
Source: SEC filing on April 1, 2019.
Mehta's colleagues
We found two more compensation records of executives who worked with Vimal Mehta at BioXcel Therapeutics in 2017.
News
BioXcel Therapeutics CEO Vimal Mehta's 2023 pay rises 4% to $4.7M
April 29, 2024
BioXcel Therapeutics CEO Vimal Mehta's 2022 pay falls 51% to $4.6M
May 17, 2023
BioXcel Therapeutics CEO Vimal Mehta's 2021 pay slips 2% to $9.4M
April 5, 2022
BioXcel Therapeutics CEO Vimal Mehta's 2020 pay jumps 386% to $9.6M
April 27, 2021
BioXcel Therapeutics CEO Vimal Mehta's 2019 pay jumps 181% to $2M
April 6, 2020
BioXcel Therapeutics CEO Vimal Mehta's 2018 pay jumps 147% to $702K
April 1, 2019